Universal Ibogaine Inc (V:IBO) — Market Cap & Net Worth
Market Cap & Net Worth: Universal Ibogaine Inc (IBO)
Universal Ibogaine Inc (V:IBO) has a market capitalization of $1.13 Million (CA$1.56 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #30624 globally and #1570 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Universal Ibogaine Inc's stock price CA$0.01 by its total outstanding shares 312858516 (312.86 Million). Also see Universal Ibogaine Inc total assets for a full breakdown of the balance sheet.
Universal Ibogaine Inc Market Cap History: 2021 to 2026
Universal Ibogaine Inc's market capitalization history from 2021 to 2026. Data shows change from $28.29 Million to $1.13 Million (-51.73% CAGR). Also see IBO operating cash flow for how efficiently the company converts equity into cash flow.
Universal Ibogaine Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Universal Ibogaine Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Universal Ibogaine Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.49x
Universal Ibogaine Inc's market cap is 0.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $3.39 Million | $1.07 Million | -$10.50 Million | 3.17x | N/A |
| 2023 | $1.13 Million | $1.03 Million | -$2.39 Million | 1.10x | N/A |
| 2024 | $1.13 Million | $2.33 Million | -$2.05 Million | 0.49x | N/A |
Competitor Companies of IBO by Market Capitalization
Companies near Universal Ibogaine Inc in the global market cap rankings as of September 17, 2026. Review how tangible is Universal Ibogaine Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Universal Ibogaine Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Universal Ibogaine Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Universal Ibogaine Inc's market cap moved from $28.29 Million to $ 1.13 Million, with a yearly change of -51.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.13 Million | 0.00% |
| 2025 | CA$1.13 Million | 0.00% |
| 2024 | CA$1.13 Million | 0.00% |
| 2023 | CA$1.13 Million | -66.67% |
| 2022 | CA$3.39 Million | -88.00% |
| 2021 | CA$28.29 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Universal Ibogaine Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Million USD |
| MoneyControl | $1.13 Million USD |
| MarketWatch | $1.13 Million USD |
| marketcap.company | $1.13 Million USD |
| Reuters | $1.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Universal Ibogaine Inc
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.